CRISPR/Cas12a-Responsive Smart DNA Hydrogel for Sensitive Electrochemiluminescence Detection of the Huanglongbing Outer Membrane Protein Gene.
Yutian ZhangCan HuYashi YinKejing RenYingsi HeYanru GaoHe-You HanChengzhou ZhuWenjing WangPublished in: Analytical chemistry (2024)
Citrus Huanglongbing (HLB) is known as the cancer of citrus, where Candidatus Liberibacter asiaticus ( C Las) is the most prevalent strain causing HLB. In this study, we report a novel electrochemiluminescence (ECL) biosensor for the highly sensitive detection of the C Las outer membrane protein (Omp) gene by coupling rolling circle amplification (RCA) with a CRISPR/Cas12a-responsive smart DNA hydrogel. In the presence of the target, a large number of amplicons are generated through RCA. The amplicons activate the trans -cleavage activity of CRISPR/Cas12a through hybridizing with crRNA, triggering the response of smart DNA hydrogel to release the encapsulated AuAg nanoclusters (AuAg NCs) on the electrode and therefore leading to a decreased ECL signal. The ECL intensity change ( I 0 - I ) is positively correlated with the concentration of the target in the range 50 fM to 5 nM, with a limit of detection of 40 fM. The performance of the sensor has also been evaluated with 10 samples of live citrus leaves (five HLB negative and five HLB positive), and the result is in excellent agreement with the gold standard qPCR result. The sensing strategy has expanded the ECL versatility for detecting varying levels of dsDNA or ssDNA in plants with high sensitivity.
Keyphrases
- sensitive detection
- crispr cas
- loop mediated isothermal amplification
- genome editing
- circulating tumor
- quantum dots
- drug delivery
- nucleic acid
- cell free
- label free
- single molecule
- hyaluronic acid
- cancer therapy
- tissue engineering
- wound healing
- copy number
- genome wide
- papillary thyroid
- real time pcr
- circulating tumor cells
- photodynamic therapy
- squamous cell
- young adults
- gene expression
- dna methylation
- high intensity
- energy transfer
- childhood cancer
- dna binding
- silver nanoparticles